This study investigated how common symptoms of anxiety and depression are amongst patients with diabetes mellitus. This study concluded that 1 in 10 patients had symptoms of both anxiety and depression.

This study examined whether empagliflozin (Jardiance) is safe and effective in type 1 diabetics taking insulin.

This study investigated the effects of liraglutide (Victoza) during periods of low blood sugar in patients with type 1 diabetes. 

This study examined whether long-term treatment with liraglutide (Victoza) can improve kidney function and reduce blood pressure in patients with type 2 diabetes. 

This study investigated the effect of glucagon-like peptide-1 receptor agonists on cardiovascular (heart) risk in type 2 diabetes.

This review examined whether certain medications for type 2 diabetes can increase the risk of patients developing bone fractures.

This study examined the effectiveness and safety of canagliflozin (Invokana), a glucose (sugar)-lowering therapy, in older adults (aged 55 to 80) with type 2 diabetes.

This study wanted to find out the effect of the medication sotagliflozin (Zynquista) at different doses on the blood sugar levels and weight of people with type 1 diabetes. The study found that at higher doses, sotagliflozin decreased the blood sugar levels and weight of these patients.

The current study examined the long-term complications, including the need for renal replacement therapy and mortality, of type 1 diabetes.

This review explored the factors associated with heart failure risk in patients with type 2 diabetes.